Name: CytomX Therapeutics, Inc. (CTMX) Balance Sheet
Creator: FinSpry

CytomX Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for CytomX Therapeutics, Inc. (CTMX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	38.05	17.17	193.65	205.53	316.12	296.15	436.13
Short-Term Investments	62.57	157.34	0.00	99.70	124.26	0.00	0.00
Cash & Short-Term Investments	100.62	174.51	193.65	305.23	316.12	296.15	436.13
Accounts Receivable	3.10	3.43	35.99	0.79	0.80	0.01	0.10
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.58	5.00	9.27	4.29	6.45	5.25	0.00
Total Current Assets	107.31	182.94	237.10	310.30	324.01	303.34	445.48
Non-Current Assets
Property, Plant & Equipment (Net)	10.60	16.18	21.02	25.32	29.45	32.75	6.93
Goodwill	0.95	0.95	0.95	0.95	0.95	0.00	0.00
Intangible Assets	0.58	0.73	0.88	1.02	1.17	0.00	0.00
Other Non-Current Assets	1.09	1.00	0.94	1.82	3.09	2.93	2.29
Total Non-Current Assets	13.23	18.86	23.79	29.11	34.65	37.95	11.63
Total Assets	120.53	201.79	260.89	339.41	358.66	341.28	457.11
Current Liabilities
Accounts Payable	1.09	1.46	27.26	2.82	26.06	34.21	45.20
Short-Term Debt	5.15	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	12.34	17.60	22.82	30.62	19.86	0.00	0.00
Deferred Revenue	67.20	132.27	121.27	40.82	42.06	0.00	0.00
Other Current Liabilities	12.34	8.16	8.06	9.58	8.36	6.72	0.00
Total Current Liabilities	85.77	155.91	152.61	77.87	100.92	85.59	97.91
Non-Current Liabilities
Long-Term Debt	4.24	9.39	13.98	18.06	21.68	24.87	0.00
Other Non-Current Liabilities	4.12	3.89	301.33	284.76	261.13	0.85	3.05
Total Non-Current Liabilities	35.22	93.33	194.03	262.00	207.94	204.58	228.32
Total Liabilities	120.99	249.24	346.64	339.87	308.86	290.17	326.23
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-691.58	-723.45	-722.87	-623.56	-450.16	-417.17	-314.98
Accumulated Other Comprehensive Income	0.03	0.10	0.01	-0.24	-0.05	0.00	-0.09
Additional Paid-in Capital	691.10	675.91	637.12	623.34	499.96	468.29	445.96
Shares Outstanding	80.10	67.31	66.23	65.39	0.00	0.00	0.00
Total Stockholders' Equity	-0.46	-47.45	-85.75	-0.46	49.80	51.11	130.88
Total Liabilities & Equity	120.53	201.79	260.89	339.41	358.66	341.28	457.11